Is a complete ETR/KK3A research report available?

No complete published report is available for etr/KK3A (ETR/KK3A) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

ETR/KK3A (ETR/KK3A)

Deutsche Börse Xetra: ETR/KK3A · EUR

€73.9

+3.58 (+5.1%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-28 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first ETR/KK3A analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	9.6B
Revenue (ttm)	91.8M
Net income (ttm)	-719.5M
EPS (ttm)	-€5.93
Volume	0

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 91.8M
Net income (ttm): -719.5M
EPS (ttm): -€5.93
Market cap: 9.6B

All ETR/KK3A indicators

Market & fundamental data

Available fields

129

Groups with data

Currency

USD

Showing 129 of 129 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	673
Employees Change	175%
Employees Change Percent	35.14
Enterprise value	EUR 10.2B
Exchange	Deutsche Börse Xetra
Financial currency	USD
First seen	2026-07-12
Industry	Pharmaceutical Preparations
Last refreshed	2026-07-28
Market cap	EUR 9.6B
Price	EUR 73.94
Price currency	EUR
Rev Per Employee	136,364.56x
Sic	2834
Symbol	etr/KK3A
Website	https://www.cytokinetics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-7.48%
EV/Sales	109.35x
FCF yield	-4.95%
P/B ratio	-13.42x
P/S ratio	104.85x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	-290.73%
Gross Profit	EUR -266.8M
Net Income	EUR -719.5M
Pretax Margin	-784.02%
Profit Per Employee	EUR -1.1M
ROA	-31.54
Roa5y	-25.94
ROCE	-59.6
ROIC	-62.88

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Revenue Growth	450.6x
Revenue Growth Q	1,125.78x
Revenue Growth3 Y	2.57x
Revenue Growth5 Y	12.56x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.08
Assets	EUR 1.1B
Cash	EUR 709.9M
Current Assets	EUR 738.4M
Current Liabilities	EUR 175.2M
Debt	EUR 1.3B
Debt FCF	EUR -2.63
Equity	EUR -716.9M
Interest Coverage	-5.6
Liabilities	EUR 1.8B
Long Term Assets	EUR 366.1M
Long Term Liabilities	EUR 1.6B
Net Cash	EUR -542.1M
Net Cash By Market Cap	EUR -5.63
Tangible Book Value	EUR -716.9M
Tangible Book Value Per Share	EUR -5.77

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.21
Net Working Capital	EUR -71.9M
Quick ratio	4.14
Working Capital	EUR 555.3M
Working Capital Turnover	EUR 0.13

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-4.46%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
All Time High	77.3
All Time High Change	-8.15%
All Time High Date	2026-06-30
All Time Low	58.36
All Time Low Change	21.66%
All Time Low Date	2026-06-10
ATR	1.44
High	73.94
High52	77.3
High52 Date	2026-06-30
High52ch	-4.35%
Low	70.94
Low52	58.36
Low52 Date	2026-06-10
Low52ch	26.7%
RSI	57.93
RSI Monthly	0
RSI Weekly	0
Sharpe ratio	3.03x
Sortino ratio	5.65
Total Return	-4.46%
Tr1m	2.39%
Tr1w	0.11%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -555.3M
Operating margin	-605.1

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	135,155,958%
Net Borrowing	278,045,627.9
Shares Insiders	0.43%
Shares Institutions	105.07%
Shares Qo Q	2.64%
Shares Yo Y	4.46%
Short Ratio	6.48

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -579.4M
Adjusted OCF	-557,656,554
Average Volume	79.65x
Bv Per Share	-5.77
CAPEX	EUR -21.7M
Ch1m	2.39
Ch1w	0.11
Change	5.09%
Change From Open	4.23
Close	70.36
Days Gap	0.82
Depreciation Amortization	9,854,427.7
Earnings Date	2026-08-06
EBIT	EUR -555.3M
EBITDA	EUR -545.6M
EPS	EUR -5.93
F Score	3
FCF	EUR -476.1M
FCF EV Yield	-4.68x
Financing CF	457,478,200
Fiscal Year End	December
Founded	1,997
Investing CF	48,743,995
Is Primary Listing	0
Last Report Date	2026-03-31
Ma20	73.15
Ma20ch	-2.94%
Net CF	51,083,103
Next Earnings Date	2026-08-06
Open	70.94
Position In Range	100
Ppne	138,086,014.4
Price Date	2026-07-27
Relative Volume	0.01x
Revenue	91,773,350x
SBC By Revenue	112.58x
Share Based Comp	103,322,316
Volume	0
Z Score	-3.29

ETR/KK3A (ETR/KK3A)

Coverage state: Market snapshot only — no published research

Generate the first ETR/KK3A analysis

Price

Financial snapshot

Fair-value bridge

Latest news · ETR/KK3A

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ETR/KK3A indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on ETR/KK3A

Frequently asked questions